PROTEIN AND ANTIBODY THERAPEUTICS THROUGH
COLLABORATION & SCIENTIFIC RESEARCH
The 3rd Annual Biologics Congress will be held
on 6-7 March 2017 in Berlin. Providing an opportunity to
network with senior representatives of leading
pharmaceutical and biotech companies, this well received
event brought together 200 attendees in 2016.
Attracting industry, regulatory & academic experts
working in all areas of protein, antibody & biosimilar
research this two-day interactive meeting will explore a
variety of topics across three streams.
The first stream focuses on the latest innovations in antibody
based therapeutics, leaders from the industry will
be presenting updates on their strategy, pipeline and
The second stream includes presentations on expression,
purification and characterisation, discussing issues
around stability and half-life, as well as presenting
novel cancer therapy approaches.
The Biosimilars stream explores themes of
similarity, regulation and public perception, alongside
presentations on candidate generics in various stages of
development. Executive panels and roundtables will foster
discussion on the direction of the field, and the
approaches required to ensure that the industry continues
This senior level conference combines a vibrant
exhibition room, novel scientific content and ample
networking opportunities; facilitating discussion and
collaboration that is vital within the industry.